Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 5:07 AM UTC
| NCT Number | NCT06649812 |
| Recruiting Status | Recruiting |
| Condition | B-cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 87 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | August 28, 2026 (3 days ago) |
As of August 31, 2026: Clinical trial NCT06649812 is currently recruiting participants. This phase2 study for b-cell lymphoma is actively seeking new participants at 87 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06649812 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 87 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06649812 was last updated 3 days ago (August 28, 2026). HelloStudys verifies this status automatically.